FABP2 and inflammatory bowel disease: This is the first study in Romania, Eastern Europe, to include the set of biomarkers of intestinal permeability, i.e., calprotectin, zonulin, LBP and IFABP/FABP2, in the study of depression in patients with IBD for analysing whether intestinal permeability syndrome is correlated with depression.